Nutex Health (NUTX) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | -24.22% |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | -69.52% |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | 14.21% |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 5.30% |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 70.80% |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | 27.17% |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | -282.22% |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | -176.36% |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | -673.40% |
| 10 | Nutex Health | 902.46 Mn | 787.58 Mn | 91.73 Mn | -1,776.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,776.56% |
| Dec 31, 2025 | -52.04% |
| Sep 30, 2025 | -13.11% |
| Jun 30, 2025 | 115.43% |
| Mar 31, 2025 | 91.27% |
| Dec 31, 2024 | -485.45% |
| Sep 30, 2024 | 92.62% |
| Jun 30, 2024 | 58.63% |
| Mar 31, 2024 | 86.47% |
| Dec 31, 2023 | -89.02% |
| Sep 30, 2023 | 38.56% |
| Jun 30, 2023 | -235.53% |
| Mar 31, 2023 | 36.96% |
| Dec 31, 2022 | 166.95% |
| Sep 30, 2022 | -68.72% |
| Jun 30, 2022 | 108.85% |
| Mar 31, 2022 | -320.97% |
| Dec 31, 2021 | 80.78% |
| Sep 30, 2021 | -7,055.87% |
| Jun 30, 2021 | -963,869.20% |
| Dec 31, 2020 | -9,149.08% |
| Sep 30, 2020 | 302.28% |
| Jun 30, 2020 | 86.42% |
| Dec 31, 2019 | -466.05% |
| Dec 31, 2018 | -52,084.00% |
| Dec 31, 2017 | 101.50% |
| Jun 30, 2017 | 30.54% |
| Mar 31, 2017 | -236.60% |
| Dec 31, 2016 | -197.16% |
| Mar 31, 2016 | 397.37% |
| Dec 31, 2015 | 1,544,000.00% |
| Mar 31, 2015 | -6.08% |
| Mar 31, 2014 | -266.25% |
| Sep 30, 2013 | 91.70% |
| Mar 31, 2013 | 497.49% |
| Dec 31, 2012 | -100.86% |
| Sep 30, 2012 | 96.14% |
| Jun 30, 2012 | 25.05% |
| Mar 31, 2012 | 77.88% |
| Dec 31, 2011 | -72.16% |
| Sep 30, 2011 | 74.18% |